Eigen Therapeutics

Cold Start Therapeutics

This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Alceus

This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.

Cellular Intelligence

This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.

Meliora Therapeutics

This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.

Ataraxis AI

This company develops artificial intelligence models that predict cancer outcomes and treatment responses for healthcare providers and oncologists.

TenSixty Bio

The company develops an artificial intelligence platform to discover tumor-selective epitopes and create antibody-based therapeutics for healthcare providers and oncology patients.